Gemtuzumab Ozogamicin (Mylotarg) and hepatic veno-occlusive disease: take two acetaminophen, and

被引：11

作者：

Gordon, L ^{[1
]}

机构：

[1] Northwestern Univ, Sch Med, Dept Med,Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

来源：

BONE MARROW TRANSPLANTATION | 2001年 / 28卷 / 09期

关键词：

D O I：

10.1038/sj.bmt.1703241

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：811 / 812

页数：2

共 27 条

[1] Veno-occlusive disease of the liver [J].

Bearman, SI .

CURRENT OPINION IN ONCOLOGY, 2000, 12 (02) :103-109

[2] VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - POSSIBLE ASSOCIATION WITH GRAFT VERSUS HOST DISEASE [J].

BERK, PD ;

POPPER, H ;

KRUEGER, GRF ;

DECTER, J ;

HERZIG, G ;

GRAW, RG .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (02) :158-164

[3]

BRAS G, 1954, AMA ARCH PATHOL, V57, P285

[4] Veno-occlusive disease of the liver after hemopoietic cell transplantation [J].

Carreras, E .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (05) :281-291

[5] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma [J].

Cavo, M ;

Bandini, G ;

Benni, M ;

Gozzetti, A ;

Ronconi, S ;

Rosti, G ;

Zamagni, E ;

Lemoli, RM ;

Bonini, A ;

Belardinelli, A ;

Motta, MR ;

Rizzi, S ;

Tura, S .

BONE MARROW TRANSPLANTATION, 1998, 22 (01) :27-32

[6]

Cushny AR, 1911, J PHARMACOL EXP THER, V2, P531

[7] Characterization of a reproducible rat model of hepatic veno-occlusive disease [J].

DeLeve, LD ;

McCuskey, RS ;

Wang, XD ;

Hu, LP ;

McCuskey, MK ;

Epstein, RB ;

Kanel, GC .

HEPATOLOGY, 1999, 29 (06) :1779-1791

[8]

DeLeve LD, 1996, HEPATOLOGY, V23, P589

[9] Glutathione defense in non-parenchymal cells [J].

Deleve, LD .

SEMINARS IN LIVER DISEASE, 1998, 18 (04) :403-413

[10]

DURKEN M, 1995, BONE MARROW TRANSPL, V15, P757

← 1 2 3 →